Imagine a corporate boardroom where the air is thick with tension, not over market shares or quarterly earnings, but over a staggering 9% hike in healthcare costs projected for next year. For employers across the nation, this figure isn’t just a number—it’s a looming crisis that threatens to disru
Imagine a nation once known primarily for its agricultural roots now stepping boldly onto the global stage, aiming to become a powerhouse in a market projected to reach a staggering US$3.88 trillion by 2030. Vietnam, with its rapidly evolving biotechnology sector, is doing just that. This Southeast
In a landscape where rare disease treatments often struggle to gain traction, the recent $130 million Series B financing secured by San Diego-based biotech startup Protego Biopharma stands as a beacon of potential. This substantial investment, aimed at advancing the first-in-class drug candidate
Imagine a healthcare landscape where cutting-edge diagnostic imaging not only saves lives but redefines patient care through precision and speed. In France, this vision is becoming a reality as diagnostic imaging emerges as a cornerstone of modern medicine. Amid this dynamic environment, Excellence
Faisal Zain has spent years at the coalface of medical technology, from designing diagnostic components to scaling manufacturing lines that feed front-line care. That vantage point gives him a pragmatic view of how capital actually enables innovation in clinics and factories—not just in pitch d
A swift sequence of disclosures, market reactions, and legal milestones shaped a clear chronology for investors who bought Molina Healthcare, Inc. (NYSE: MOH) securities in early to mid-2025 and then saw risk details emerge that allegedly cut against prior guidance and cost trend assumptions,
